Dison Pharma SRL
2.3 FTEThe score of Dison Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +110 % Total assets -5 % Headcount (avg FTE) +35 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dison Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 76,391 € | ||||
| Equity | 301,711 € | ||||
| Cash | 248,721 € | ||||
| EBITDA | 149,552 € | ||||
| Total assets | 638,498 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 01 Aug 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Dison Pharma's financial analysis
- Solvency47.3%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dison Pharma
Dison Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0640.801.992
- VAT number
- BE0640801992
- Peppol
- Registered · 0208:0640801992 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Oct 2015
- Registered office
- 4820 Dison
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dison Pharma (SRL) has been based in Dison since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 76,391 € and equity of 301,711 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 47.3%, above the median of its sector (41.5%).
Companies similar to Dison Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Dubois Nortier Retail sale of pharmaceutical products Verviers · balance sheet 643,636 €
- Apotheek Rondpunt Sleidinge Retail sale of pharmaceutical products Evergem · balance sheet 638,365 €
- Pharma Meerhout Retail sale of pharmaceutical products Meerhout · balance sheet 637,419 €
- Apoteek Coppens Retail sale of pharmaceutical products Haaltert · balance sheet 635,784 €
- Farmaphar Retail sale of pharmaceutical products Sint-Katelijne-Waver · balance sheet 634,998 €
- J. Van Gyseghem Retail sale of pharmaceutical products Ninove · balance sheet 644,052 €
- Francart-Delfosse Pharma Retail sale of pharmaceutical products Courcelles · balance sheet 645,104 €
- Corum Mariakerke Retail sale of pharmaceutical products Ghent · balance sheet 666,044 €
Frequently asked questions about Dison Pharma
What is the revenue of Dison Pharma?
Dison Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dison Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0640801992 for Dison Pharma, if the company is VAT-registered. Its company number (CBE) is 0640.801.992.
Where is the registered office of Dison Pharma?
According to the CBE register, the registered office of Dison Pharma is in 4820 Dison.
What is the equity of Dison Pharma?
At the close of the 2025 financial year, the equity of Dison Pharma amounts to 301,711 €, a solvency of 47.3% of total assets.
How many people work at Dison Pharma?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Dison Pharma?
The register lists 1 active mandates at Dison Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dison Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →